Abstract:BACKGROUND:To investigate the protective efficacy of miR-155 on down regulating NADPH oxidase isoform subunit A1 (NoxA1) gene expression, resulting in inhibition of VSMC migration and over proliferation and thus ameliorating the progression of arterial atherosclerosis in AS mouse model. Therefore, to further explore the regulatory effect of miR-155 on neointima formation in AS and locate potential anti-atherosclerosis target.METHODS:The mouse vascular aorta smooth muscle cell (MOVAS) was cultured and transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment into 4 groups. Western blotting and RT-PCR were performed to identify the expression of NoxA1 under different circumstances. Fluorescence microscope was applied to observe the transfection rate of miR-155 into adenovirus. Twelve-week fatty food induced atherosclerotic ApoE-/- mouse model was established as host to accept miR-155 transfected adenovirus transplantation to observe its effect on VSMC in AS progression. Carotid and thoracic artery were extracted at 1 month after dosing. Distribution of miR-155 was quantified via expression levels of protein and RNA to detect NoxA1, Nox1, p47phox and NADPH expression. Immunohistochemistry, fluorescence imaging and other methods were performed in arteries section to compare the thickness of neointima and assess the severity of AS in each group.RESULTS:Luciferase reporter gene assay showed significant expression of miR-155 in mimic group indicating that miR-155 had target binding effect with NoxA1 gene. Western blotting and RT-PCR results both showed significantly decreased NoxA1 expression in miR-155 mimic group while increased with its inhibitor. The miR-155 distribution was observed varied at 1 month after in control, miR-155 mimic and inhibitor groups. The NoxA1, NADPH, Nox1 and pp47phox protein expression in VSMC was decreased in mimic group vs control and inhibitor groups (P<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1, Nox1 and p47phox gene expression in VSMC were both found reduced compared with those of control group at week 4 (P<0.05). Immunohistochemistry staining of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (P<0.01) at week 4.CONCLUSIONS:miR-155 played an important role in NoxA1-related signaling pathway. miR-155 transfection into VSMC may have anti-inflammatory regulatory effect on NoxA1 expression in vivo and resulting in amelioration of atherosclerotic lesion in AS mouse model. In summary, miR-155 specifically plays in a negative feedback loop and demonstrates a protective role during atherosclerosis-associated VSMC proliferation and neointima formation through the miR-155-NoxA1-p47phox complex signaling pathway.

MiR-301a regulates the expression of inflammatory factors in macrophages

Microrna-181A Represses Ox-Ldl-stimulated Inflammatory Response in Dendritic Cell by Targeting C-Fos

MiR-155 Acts As an Inhibitory Factor in Atherosclerosis-Associated Arterial Pathogenesis by Down-Regulating NoxA1 Related Signaling Pathway in ApoE-/- Mouse.

Regulation of Microrna-155 in Atherosclerotic Inflammatory Responses by Targeting Map3k10

Abstract 8510: Regulation of Microrna-155 of the Atherosclerotic Inflammatory Responses by Targeting Map3k10

MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7

Mir-21 Attenuates Lipopolysaccharide-Induced Lipid Accumulation and Inflammatory Response: Potential Role in Cerebrovascular Disease

Interfering Microrna-410 Attenuates Atherosclerosis Via the HDAC1/KLF5/IKBα/NF-κB Axis

MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis

MicroRNA‐181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP‐1 macrophages stimulated by ox‐LDL

MircroRNA-19a Promotes Vascular Inflammation and Foam Cell Formation by Targeting HBP-1 in Atherogenesis

MiR-302a Limits Vascular Inflammation by Suppressing Nuclear Factor-κ B Pathway in Endothelial Cells

MicroRNA-21 Deficiency Attenuated Atherogenesis and Decreased Macrophage Infiltration by Targeting Dusp-8

Mir-223 Inhibits Lipid Deposition And Inflammation By Suppressing Toll-Like Receptor 4 Signaling In Macrophages

miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE−/− mice

Microrna-16 Suppresses The Activation Of Inflammatory Macrophages In Atherosclerosis By Targeting Pdcd4

MicroRNA‐424‐5p Regulates Aortic Smooth Muscle Cell Function in Atherosclerosis by Blocking APOC3‐mediated Nuclear Factor‐κb Signalling Pathway

The Effects of Mir-467B on Lipoprotein Lipase (LPL) Expression, Pro-Inflammatory Cytokine, Lipid Levels and Atherosclerotic Lesions in Apolipoprotein E Knockout Mice

Mir-378a Modulates Macrophage Phagocytosis And Differentiation Through Targeting Cd47-Sirp Alpha Axis In Atherosclerosis

Downregulation of microRNA‐135b promotes atherosclerotic plaque stabilization in atherosclerotic mice by upregulating erythropoietin receptor

Microrna‐107 Protects Against Inflammation and Endoplasmic Reticulum Stress of Vascular Endothelial Cells Via KRT1‐dependent Notch Signaling Pathway in a Mouse Model of Coronary Atherosclerosis